A pharmaceutically acceptable salt of tricyclic heteroaryl piperazines, pyrrolidines and azetidine as serotonin receptor modulators

Abstract

The present invention relates to salts of hexahydroazepinoindole and octahydroazepinoindole compound, pharmaceutical composition containing the salt of these compounds and to use of the provided salt and composition as therapeutic agents. This compound is serotonin receptor (5-HT) ligands and is useful for treating disease, disorders and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e.g. anxiety, depression and obesity).